Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy

CompletedOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

April 7, 2017

Primary Completion Date

March 15, 2019

Study Completion Date

March 15, 2019

Conditions
Epilepsy
Interventions
DRUG

Fycompa

Oral suspension

Trial Locations (44)

10003

Albert Einstein College of Medicine, New York

10032

Columbia University Medical Center, New York

10075

Northwell Health, New York

10530

Icahn School of Medicine at Mount Sinai, Hartsdale

15212

Pennsylvania, Pittsburgh

19141

Albert Einstein Medical Center, Philadelphia

20817

Mid-Atlantic Epilepsy and Sleep Center, Bethesda

27710

Duke University Medical Center, Durham

31406

Meridian Clinical Research, Savannah

32801

Nemours Children's Hospital, Orlando

32819

Pediatric Neurology PA, Orlando

33155

Nicklaus Children's Hospital, Miami

33486

Boca Raton Regional Hospital, Boca Raton

33606

University of South Florida, Tampa

33818

Capernaum Medical Center, Lakeland

34233

Doctors hospital of Sarasota, Sarasota

34239

Intercoastal Medical Group, Sarasota

38105

Le Bonheur Children's Hospital - PIN, Memphis

46804

Fort Wayne Neurological Center, Fort Wayne

48201

Wayne State University, Detroit

48202

Henry Ford Health System, Detroit

Spectrum Health System, Detroit

49503

Spectrum Health Medical Group, Grand Rapids

55102

Minnesota Epilepsy Group, Saint Paul

61801

Carle Foundation Hospital, Urbana

77030

University of Texas Health Science Center at Houston, Houston

78758

Austin Epilepsy Center, Austin

80907

Colorado Springs Neurological Associates, Colorado Springs

83702

Consultants in Epilepsy & Neurology PLLC, Boise

85006

Arizona Age Reversal & Neurology Clinic, Phoenix

Bronislava Shafran, MD, PC, Phoenix

85013

Banner - University Medical Center Phoenix, Phoenix

85351

Arizona Neurological Institute, Sun City

85724

The University of Arizona Department of Neurology, Tucson

93636

Valley Children's Hospital, Madera

95814

UC Davis Medical Center, Sacramento

95816

Sutter Health, Sacramento

97239

Oregon Health and Science University, Portland

98001

Auburn Neurological Institute, Auburn

98002

Northwest Neurology & Electrodiagnostic Center, Auburn

98105

Seattle Children's Hospital - PIN, Seattle

02111

Tufts Medical Center, Boston

07601

Northeast Regional Epilepsy Group, Hackensack

98405-4048

MultiCare Institute for Research and Innovation, Tacoma

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT03208660 - Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy | Biotech Hunter | Biotech Hunter